| Literature DB >> 32397667 |
Alina Matei1, Cristina Puscas1, Iulia Patrascu1, Maria Lehene1, Julia Ziebro2, Florina Scurtu1, Monica Baia3, Dan Porumb1, Robert Totos1, Radu Silaghi-Dumitrescu1.
Abstract
Glutaraldehyde (GA) is used as biocide in hospitals. Recent public investigations on the chemical composition of biocides used in Romania have in some cases found GA, as a key ingredient, to be apparently diluted. However, these data did not explicitly consider the complex chemical equilibria inherent to GA. An investigation of experimental and theoretical data is reported here, assessing the stability of GA solutions relevant for biocide compositions. GA solutions of various chemical composition and under varying circumstances were analyzed using spectroscopy (UV-VIS, Raman, NMR) coupled with density functional theory (DFT) calculations, as well as chemically, such as via the formation of imines in reaction/titration with glycine monitored at 270 nm; using LC-MS; or using SDS-PAGE analysis with GA as reagent in the polymerization of two test proteins- hemoglobin and myoglobin. The spectral properties of GA changed significantly over time, in a temperature-dependent manner; titration with glycine confirmed the spectral data. SDS-PAGE experiments demonstrated a non-linear and apparently unpredictable change in the reactivity of GA over time. The results may be relevant for the determination of GA concentration in various settings such as biocide analysis, hospital wastewaters, and others.Entities:
Keywords: DFT; LC–MS; NMR; Raman; SDS-PAGE; biocide; glutaraldehyde; titration
Mesh:
Substances:
Year: 2020 PMID: 32397667 PMCID: PMC7246990 DOI: 10.3390/ijms21093372
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Scheme 1Chemical structures of products shown to be present in glutaraldehyde (GA) solutions.
Figure 1Raman spectra of 1M GA incubated at the initial time (t0), room temperature, and 40 °C for 8 weeks.
Figure 21H-NMR spectra of 12.5% glutaraldehyde in D2O at varying temperatures. Chemical shifts (parentheses show, in this order: the coupling type, coupling constant when not singlet, the integrated value, and the chemical assignment to the extent available/possible) in parts per million (ppm) for room temperature: 9.611 (singlet, 2H, CHO), 5.235 (doublet of doublets, 6 Hz/2Hz, 8.31H, unsaturated), 4.972 (sextet, 2.8 Hz, 6H, unsaturated), 2.533 (quartet of doublets, 7.2 Hz/1.2 Hz, 4.29H, aliphatic), 1.832 (multiplet, not determined (n.d.), 2.21H, aliphatic), 1.702 (multiplet, n.d., 27H aliphatic), 1.566 (multiplet, n.d., 12H, aliphatic), 1.445 (multiplet, n.d., 14H, aliphatic), 1.224 (multiplet, n.d., 7H, aliphatic). At 50 °C: 9.932 (singlet, 2H, CHO), 5.555 (doublet of doublets, 4.4 Hz/1.2Hz, 1.84H, unsaturated), 5.252 (multiplet, n.d., 1.34H, unsaturated), 5.152 (doublet of doublets, 9.6 Hz/2Hz, 1.73H, unsaturated), 2.825 (quartet, 6.8 Hz, 4.34H, aliphatic), 1.832 (multiplet, n.d., 1.91H, aliphatic), 1.224 (multiplet, n.d., 16H, aliphatic). At 70 °C: 10.120 (singlet, 2H, CHO), 5.723 (doublet, 4 Hz, 0.73H, unsaturated), 5.465 (multiplet, n.d., 0.67H, unsaturated), 5.300 (doublet, 10.4 Hz, 0.66H, unsaturated), 3.022 (quartet, 7.2 Hz, 4.14H, aliphatic), 2.338 (quintet, 8.4 Hz, 2.02H, aliphatic), 2.127 (multiplet, n.d., 7.35H, aliphatic), 1.933 (multiplet, n.d., 0.73H, aliphatic).
Thermodynamic parameters derived from the temperature dependence of the glutaraldehyde solution NMR spectra.
| T (K) | ΔS (kcal/mol*K) | ΔH (kcal/mol) | ΔG (kcal/mol) |
|---|---|---|---|
| 293 | −0.02 | −7.78 | −1.27 |
| 323 | −0.60 | ||
| 343 | −0.15 |
LC-MS chromatographic results and corresponding notable MS data (where assignments could be made). Chromatograms and spectra are shown in the Supplementary Information Figures S5–S8.
| Sample | Peak 1 (Rf/rel. area) | Peak 2 (Rf/rel. area) | Notable MS Signals in Peak 1 | Notable MS Signals in Peak 2 |
|---|---|---|---|---|
| GA control, 0.3 M | 0.573/100 | 0.855/41 | 101 (GA), 119 (II), 165 (VI/X minus water), 183 (VI/X, or IX minus water) | N.D.a |
| GA 0.3 M incubated 4 weeks at 40 °C | 0.632/5 | 0.829/100 | N.D.a | 201 (IX), N.D.a |
| GA control, 2.5 M | 0.581/100 | 0.837/20 | 101 (GA), 165 (VI/X minus water), 183 (VI/X, or IX minus water) | 101 (GA), 119 (II), 183 (VI/X), or IX minus water), N.D.a |
| GA 2.5 M, incubated for 5 h at 70 °C | 0.581/100 | 0.837/18 | 101 (GA), 165 (VI/X minus water), 183 (VI/X, or IX minus water) | 101 (GA), 183 (VI/X, or IX minus water), N.D.a |
a Most or all of the signals were not assignable to any of the structures of Scheme 1.
Figure 3Time evolution for 8 weeks of GA concentration at 40 °C and at room temperature, as measured by titration with glycine.
Figure 4A 12% SDS-PAGE of 1.5 mM haemoglobin polymerization with varying concentrations of GA: 1; 2: 0 mM; 3: 0.5 mM; 4: 1 mM; 5: 3 mM; 6: 5 mM; 7: 7 mM; 8: 3 mM, room temperature (RT), week 8; 9: 5 mM, RT, week 8; 10: 3 mM, 40 °C, week 8; 11: 5 mM, 40 °C, week 8; 12: 3 mM, 1.2% isopropanol; 13: 3 mM, isopropanol, 60 °C, 5 h; 14: 5 mM, isopropanol, 60 °C, 5 h; 15: 3 mM isopropanol, 40 °C, week 8. For a similar experiment with myoglobin, see Figure S14. See also Figure S15 for monitoring the GA UV-vis spectra upon incubation at 60 °C.
Profile of relative intensities of protein bands.
| Sample / ≈MW (kDA) | 250 | 130 | 100 | 70 | 55 | 35 |
|---|---|---|---|---|---|---|
| 0 mM GA | 0 | 0 | 0 | 0.01 | 0.49 | 1 |
| 0.5 mM GA | 0.01 | 0 | 0.01 | 0.06 | 0.61 | 1 |
| 1 mM GA | 0 | 0 | 0.03 | 0.18 | 0.81 | 1 |
| 3 mM GA | 0 | 0.05 | 0.34 | 0.49 | 1 | 0.82 |
| 5 mM GA | 0.08 | 0.43 | 0.65 | 0.56 | 1 | 0.67 |
| 7 mM GA | 0.28 | 0.51 | 0.68 | 0.58 | 1 | 0.67 |
| 3 mM GA, RT, week 8 | 0.65 | 0.64 | 0.58 | 0.57 | 1 | 0.77 |
| 5 mM GA, RT, week 8 | 1 | 0.6 | 0.52 | 0.36 | 0.75 | 0.52 |
Figure 5Evolution of absorbance in the UV-VIS spectra of 28.2 mM GA, at room temperature (A) and at 40 °C (B), for 8 weeks. See also Figures S10–S13.
Figure 6Comparison of the UV-VIS spectra of GA solutions, with spectra computed for GA and for a number of its reaction products.